Pages that link to "Q38980189"
Jump to navigation
Jump to search
The following pages link to Epidermal growth factor receptor targeting IgG3 triggers complement-mediated lysis of decay-accelerating factor expressing tumor cells through the alternative pathway amplification loop. (Q38980189):
Displaying 7 items.
- Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation (Q28076193) (← links)
- Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity (Q37163679) (← links)
- Monoclonal Antibodies against Epidermal Growth Factor Receptor Acquire an Ability To Kill Tumor Cells through Complement Activation by Mutations That Selectively Facilitate the Hexamerization of IgG on Opsonized Cells. (Q38722574) (← links)
- Type I CD20 Antibodies Recruit the B Cell Receptor for Complement-Dependent Lysis of Malignant B Cells. (Q38733785) (← links)
- A Complement-Optimized EGFR Antibody Improves Cytotoxic Functions of Polymorphonuclear Cells against Tumor Cells. (Q38827226) (← links)
- Distinct CD55 Isoform Synthesis and Inhibition of Complement-Dependent Cytolysis by Hepatitis C Virus (Q39644772) (← links)
- Antibody Isotypes for Tumor Immunotherapy (Q42660171) (← links)